Cellectricon receives breakthrough order from AstraZeneca
Cellectricon receives breakthrough order from AstraZeneca The Swedish biotech tools company Cellectricon has received a breakthrough order from AstraZeneca R&D Mölndal. The order represents an important landmark for Cellectricon's commercialization of its patented DynaflowTM technology for aggressive productivity increase in the drug discovery process. Cellectricon was formed 2001 with an extensive patent portfolio. The company has been expanding steadily and rapidly from the start, growing from 2 to 25 employees today. Cellectricon's first product, the DynaflowTM Microchip, is a ground-